Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with different antigenic variants, has posed a significant threat to public health. It is urgent to develop inhalable vaccines, instead of injectab...

Source: Journal of Nanobiotechnology - February 27, 2024 Category: Nanotechnology Authors: Shuqi Wang, Peiyang Ding, Lingli Shen, Daopeng Fan, Hanghang Cheng, Jian Huo, Xin Wei, Hua He and Gaiping Zhang Tags: Research Source Type: research